PHAT

Phathom Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$11.34

Market Cap

$893.58M

Beta

0.56

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+216.93%

EPS Growth (YoY)+42.80%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-18.66%

Debt / Equity0.00

Interest Coverage-0.9x

No credit card required

Already have an account? Sign in to view the full analysis for PHAT.